Common Stock and Warrants (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Dec. 13, 2023 |
Apr. 18, 2025 |
Jan. 17, 2024 |
Feb. 25, 2022 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Apr. 30, 2025 |
Nov. 29, 2023 |
|
| Warrant description | In connection with a private placement transaction completed on April 18, 2025, the Company issued 1,050,000 of common stock and 500,000 pre-funded warrants to purchase common stock at an exercise price of $1.00 per share. The warrants are immediately exercisable, have no expiration date and are subject to a beneficial ownerhip limitation of 9.99%. | |||||||
| Fair value modification of warrants recorded as stock issuance costs | $ 423,800 | |||||||
| Securities purchase agreement, description | the Company completed the last closing of its sale of securities pursuant to the 2023 Purchase Agreement discussed above. On this closing, the Company sold an aggregate of 358,388 Units, comprising 358,388 shares of the Company’s common stock and Warrants to purchase 358,388 shares of Common Stock for a total consideration of $716,776. The Company recognized $98,700 of issuance cost, which includes $71,100 attributable to legal and placement agent fees and $27,600 attributable to the fair value of warrants, issued to the placement agent, to purchase up to 17,919 shares of Common Stock at an exercise price of $2.00 per share on substantially the same terms as the Warrants issued to the purchasers of Units | |||||||
| Common share authorized capital increase | 30,000,000 | |||||||
| Proceeds from common stock | $ 7,000,000 | $ 2,050,000 | 716,800 | |||||
| Issuence and sold aggregate shares of common stock and warrants | 3,500,000 | 3,750,000 | ||||||
| Warrants to purchase | 358,388 | |||||||
| Exercise price | $ 2.00 | |||||||
| Replacement warrants, outstanding | 333,884 | |||||||
| 2022 Equity Incentive Plan (the "2022 Plan") | ||||||||
| Issuance of shares | 1,750,000 | |||||||
| 2023 Securities Purchase Agreement | ||||||||
| Securities purchase agreement, description | the Company entered into a Securities Purchase Agreement (“the 2023 Purchase Agreement”) with certain investors (collectively, the “Investors”) pursuant to which the Investors agreed to subscribe and purchase up to 3,500,000 Units at a price per Unit of $2.00, or an aggregate purchase price of $7,000,000 at which included warrants (the “Warrants”) at an exercise price of $2.50 per share. The Warrants were immediately exercisable and expire five years from their date of issuance. If at any time commencing 12 months from the date of the issuance of a Warrant, but before the expiration of the Warrant, the volume weighted average pricing of the Company’s common stock exceeds $5.00 (subject to adjustment for forward and reverse stock splits, recapitalizations | |||||||
| Warrants to purchase | 157,081 | |||||||
| Exercise price | $ 2.00 | |||||||
| Equity issuance cost | $ 645,100 | |||||||
| 2023 Securities Purchase Agreement | Investor [Member] | Private Placement [Member] | ||||||||
| Warrant to purchase | 500,000 | |||||||
| Pre-funded warrants | 1,050,000 | |||||||
| Stock purchased | 1,550,000 | |||||||
| 2023 Securities Purchase Agreement | Investor [Member] | Private Placement [Member] | Warrants | ||||||||
| Warrant to purchase | 1,550,000 | |||||||
| Legal and placement agent fees | $ 97,800 | |||||||
| Total consideration | $ 1,550,000 | |||||||
| Pre Funded Warrants [Member] | ||||||||
| Warrants remain outstanding | 625,000 | |||||||